Select Medical (SEM)
(Delayed Data from NYSE)
$12.57 USD
-2.22 (-15.01%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $12.58 +0.01 (0.08%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SEM 12.57 -2.22(-15.01%)
Will SEM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SEM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SEM
Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates
Humana (HUM) Q2 Earnings Lag Estimates
SEM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Select Medical (SEM) is a Top Value Stock for the Long-Term
Select Medical Expands Presence in Tennessee With Ballad Health Deal
Here's Why Select Medical (SEM) is a Strong Value Stock
Other News for SEM
Select Medical Holdings Corp (SEM) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Q2 2025 Select Medical Holdings Corp Earnings Call Transcript
Relative Strength Alert For Select Medical Holdings
Select Medical reaffirms $5.3B–$5.5B 2025 revenue outlook as inpatient rehab expansion accelerates
Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript